Change by the passage of time on the oxygen uptake of the rat brain homogenate by the addition of coumarin derivatives in various percentage concentrations and at 2×10
-4 molar concentration was examined.
1) Acceleration of oxygen uptake was observed in barbital (I), coumarin-3-carboxylic acid diethylamide (II), 3, 4-dihydro-4-methylcoumarin (III), 4-methylcoudarin (IV), 4-methylumbelliferone (V), 4-methyl-β-naphthapyrone (VI), coumarin-4-carboxylic acid diethylamide (VII), isocoumarin-3-carboxylic acid diethylamide (VIII), and Dormison “Schering” (IX) in low concentrations and suppression of oxygen uptake in 10-100mg% concentrations.
2) Suppression of oxygen uptake by various compounds in around 2×10
-4 molar concentration was found to become stronger with the passage of time, after addition of the chemical.
3) In such a case, suppression of oxygen uptake 50 minutes after addition of the chemicals was in the order of (I), (II), (VIII), (IX), (IV), (V), (VI) and Krebs-Ringer phosphate glucose solution (control). No significant difference could be observed between (I) and (II), (II) and (VIII), (VIII) and (IX), (IX) and (IV), and (V) and (VI), but a significant difference was observed between the control compound and various compounds, and between (V) and (VI) and other compounds (p=0.05).
4) Suppression of oxygen uptake 90 minutes after the addition of the chemical was in the order of (I), (IX), (IV), (VIII), (II), (VI), (V), and control. No significant difference was observed between (I), (IX), (IV), and (VIII), and between (II) and (VI), but a significant difference was observed between the control and various compounds tested, and between (VI) and (I), (IX), and (VIII) (p=0.05).
5) In 2×10
-4 molar concentration, the strength of such suppression falls in the order of derivatives which show clinical hypnotic action, and the control, with significant difference between these groups, but there is no significant difference between the compounds which show clinical hypnotic action.
抄録全体を表示